methylnitrosourea has been researched along with fenretinide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Detrisac, CJ; Kelloff, GJ; Mehta, RG; Moon, RC; Ratko, TA | 1 |
| Detrisac, CJ; Dinger, NM; Kelloff, GJ; Moon, RC; Ratko, TA; Thomas, CF | 1 |
| Dinger, NM; Mehta, RG; Moon, RC; Nomides, CT; Pritchard, JF; Thomas, CF | 1 |
| Dinger, NM; Dowlatshahi, K; Mehta, RG; Moon, RC; Thomas, CF | 1 |
| Banerjee, MR; Manoharan, K | 1 |
| McCormick, DL; Moon, RC | 1 |
| Katayama, S; Levenstein, MJ; Radok, P; Silverman, J; Weisburger, JH | 1 |
| Caldwell, JA; Dinger, N; McCormick, DL; Mehta, RG; Moon, RC; Thompson, CA | 1 |
| Cohen, LA; Epstein, M; Meschter, C; Saa-Pabon, V; Zang, E | 1 |
| Anzano, MA; Kadomatsu, K; Slayter, MV; Smith, JM; Sporn, MB | 1 |
| Crist, KA; Kelloff, GJ; Lubet, RA; Steele, VE; Wang, Y; You, M | 1 |
| Bosland, MC; Dooley, L; Kelloff, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Eto, I; Grubbs, CJ; Juliana, MM; Kelloff, GJ; Lubet, RA; Rodríguez-Burford, C; Steele, VE | 1 |
| Christov, K; Green, A; Shilkaitis, A | 1 |
| Anderson, AS; Eto, I; Grizzle, WE; Grubbs, CJ; Johanning, GL; Rodríguez-Burford, C; Steele, VE; Stockard, CR; Weiss, HL | 1 |
| Ding, H; Feugang, JM; Qian, L; Shao, P; Wang, X; Wu, S; Yang, J; Zhou, J; Zou, C | 1 |
| Carvalho Dartora, VFM; Costa, SKP; Fantini, MCA; Lopes, LB; Machado-Neto, JA; Malagó, ID; Marçal Pessoa, AF; Salata, GC | 1 |
17 other study(ies) available for methylnitrosourea and fenretinide
| Article | Year |
|---|---|
Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Topics: Androstenes; Animals; Antineoplastic Agents; Dehydroepiandrosterone; Diet; Drug Therapy, Combination; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Tretinoin | 1991 |
Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation, Preclinical; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Tamoxifen; Tretinoin | 1989 |
Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
Topics: Administration, Oral; Animals; Diet; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Tretinoin | 1989 |
Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Remission Induction; Tamoxifen; Tretinoin | 1989 |
beta-Carotene reduces sister chromatid exchanges induced by chemical carcinogens in mouse mammary cells in organ culture.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; beta Carotene; Carcinogens; Carotenoids; Cell Transformation, Neoplastic; Diethylnitrosamine; Female; Fenretinide; Mammary Glands, Animal; Methylnitrosourea; Mice; Organ Culture Techniques; Retinoids; Sister Chromatid Exchange; Tretinoin | 1985 |
Retinoid-tamoxifen interaction in mammary cancer chemoprevention.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Ovariectomy; Rats; Rats, Inbred Strains; Tamoxifen; Tretinoin | 1986 |
Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Tretinoin | 1983 |
Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Castration; Diet; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Time Factors; Tretinoin | 1982 |
Interactions between 4-HPR and diet in NMU-induced mammary tumorigenesis.
Topics: Animals; Diet; Edible Grain; Female; Fenretinide; Liver; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred F344; Weight Gain | 1994 |
Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading.
Topics: Animals; Evaluation Studies as Topic; Fenretinide; Genital Neoplasms, Male; Male; Methylnitrosourea; Neoplasm Staging; Prostatic Neoplasms; Rats; Rats, Wistar; Seminal Vesicles; Testosterone | 1994 |
Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis.
Topics: Animals; Anticarcinogenic Agents; Base Sequence; Carcinogens; Codon; DNA Primers; Drug Administration Schedule; Feeding Behavior; Female; Fenretinide; Genes, ras; Immunohistochemistry; Mammary Neoplasms, Experimental; Methylnitrosourea; Mutation; Rats; Rats, Sprague-Dawley; S Phase; Weight Gain | 1997 |
Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Carcinogens; Cocarcinogenesis; Fenretinide; Male; Methylnitrosourea; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone | 1998 |
Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
Topics: Animals; Anticarcinogenic Agents; Diterpenes; Energy Intake; Female; Fenretinide; Food Deprivation; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Retinyl Esters; Vitamin A; Weight Gain | 1999 |
4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Carcinoma in Situ; Disease Progression; Drug Screening Assays, Antitumor; Female; Fenretinide; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Precancerous Conditions; Rats; Rats, Sprague-Dawley | 1999 |
Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology.
Topics: Alkylating Agents; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Northern; Body Weight; Diet, Reducing; Disease Models, Animal; Estradiol; Female; Fenretinide; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Progesterone; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley | 2002 |
Intravesical N-(4-hydroxyphenyl) retinamide and adriamycin induces apoptosis in bladder cancer.
Topics: Administration, Intravesical; Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Cell Cycle; Disease Models, Animal; Doxorubicin; Female; Fenretinide; Flow Cytometry; In Situ Nick-End Labeling; Methylnitrosourea; Rats; Rats, Wistar; Urinary Bladder Neoplasms | 2006 |
Microemulsion for Prolonged Release of Fenretinide in the Mammary Tissue and Prevention of Breast Cancer Development.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Cell Survival; Delayed-Action Preparations; Drug Liberation; Drug Screening Assays, Antitumor; Emulsions; Female; Fenretinide; Humans; Inhibitory Concentration 50; Mammary Glands, Animal; Mammary Neoplasms, Experimental; MCF-7 Cells; Methylnitrosourea; Mice; Rats | 2021 |